Basiliximab in Moderate to Severe Ulcerative Colitis

Update Il y a 4 ans
Reference: NCT00430898

Woman and Man

Extract

The purpose of this study is to assess the safety, effectiveness and pharmacokinetics of two levels of intravenous basiliximab in ulcerative colitis, compared to placebo.


Inclusion criteria

  • Ulcerative colitis


Links